Health
Largest pharmacogenetic clinical trial in cardiology shows potential benefit in individualized approach – Mirage News
Heart patients who undergo percutaneous coronary intervention (PCI) or stent placement― nonsurgical procedures to improve blood flow to the heart ― are…
Heart patients who undergo percutaneous coronary intervention (PCI) or stent placement― nonsurgical procedures to improve blood flow to the heart ― are typically prescribed anti-platelet therapy to avoid blood clots that can lead to a heart attack or stroke. New research from the international TAILOR-PCI trial, the largest pharmacogenetics clinical trial in cardiology, suggests that genetic testing could potentially be a useful tool to help select antiplatelet medication. Pharmacogenetics is the…
-
General23 hours agoPolice say new leads being pursued after baby’s body found in Alexander Heights stormwater drain
-
Noosa News22 hours agoPolice charge second man over alleged assault in Gold Coast car seller on Facebook’s Marketplace
-
Noosa News8 hours agoMan dies in Brisbane crash, women and girl rushed to hospital
-
General22 hours agoRecord Qantas fine reveals Australia’s perverse moral compass